Biomedical Laboratory Science

Wednesday, November 29, 2017

Sanima Capital Issues Sanima Equity Fund from Nov 28 to Dec 1, 2017 !

Sanima Equity Fund is being floated its public issue of 120 million (12 crore) unit shares worth Rs. 1.20 billion (arba) for 4 days starting from November 28th 2017 (Mangsir 12th, 2074) till December 1st 2017 (Mangsir 15th, 2074).

The Equity Fund is a closed-end 7-years equity oriented mutual fund scheme with fund size of Rs. 1.20 billion (arba). The mutual fund is managed by Sanima Capital Limited, a subsidiary company of Sanima Bank Limited (SANIMA), its fund sponsor.

Out of the total units, 15 percent, i.e., 18 million mutual fund units have been allocated to the promoter of the mutual fund, Sanima Bank and the remaining units will be issued to the general public.

Check the link below to see or download the NOTICE:

NOTICE LINK

The offer will close on December 1st 2017 (Mangsir 15th, 2074) at the earliest, else the maximum closing date for the offer is December 12th 2017 (Mangsir 26th, 2074).

Interested people must apply for a minimum of 100 units of share and can apply maximum for up to 2.4 million unit of shares.

Check the link below to see or download the AAHWAANPATRA RELEASE:

AAHWAANPATRA LINK

The mutual fund will be issuing a total of 12 crore unit of ordinary shares worth Rs. 1.20 billion (arba) at face value of Rs. 10 per unit.

Check the link below to see or download the PROSPECTUS:

PROSPECTUS LINK

Check the link below to see or download the PRESS RELEASE:

PRESS RELEASE LINK

Interested applicants can apply through ASBA-approved banks from all 75 districts across the country.

Check the link below to apply using online step-by-step ASBA SERVICE:

ASBA ONLINE LINK

ShareUpdateNepal: Wednesday November 29th, 2017 !

Click here to see why mutual funds are best to invest

Click here to see the list of ASBA member BFIs

Saturday, November 18, 2017

Roitt's Essential Immunology, 13th Edition !

Roitt's Essential Immunology, 13th Edition pdf

Roitt's Essential Immunology, 13th Edition pdf ebook

Roitt's Essential Immunology - the textbook of choice for students and instructors of immunology worldwide

Roitt’s Essential Immunology clearly explains the key principles needed by medical and health sciences students, from the basis of immunity to clinical applications. A brand new introduction sets the scene to section 1, Fundamentals of Immunology, introducing the microbial world and the strategies the body employs to defend itself. Each chapter then guides the reader through a different part of the immune system, and explains the role of each cell or molecule individually, and then as a whole. Section 2, Applied Immunology, discusses what happens when things go wrong, and the role the immune system plays alongside the damaging effects of a disease, including cancer, immunodeficiency, allergies and transplantation and the beneficial effects of vaccines......

Estradiol Patches Now Fully Subsidized: What Is Their Place In The Treatment Of Menopausal Symptoms?

Transdermal estradiol patches (25, 50 and 100 microgram Estradot brand patches) are now fully subsidised, without the need for Special Authority approval, as a form of menopausal hormone therapy (MHT) for the treatment of menopausal symptoms. From 1 January, 2017, a 75 microgram patch will also be available.

Previously, Climara brand 50 and 100 microgram patches were available through Special Authority funding. The Special Authority funding for these medicines was removed on 1 October, 2016, and Climara brand 50 and 100 microgram patches will be delisted from 1 January, 2017. Patients who are currently using Climara patches and require ongoing treatment will need to switch to Estradot brand patches.

Source: bpac

Sunday, November 12, 2017

Siddhartha Equity Fund Allotment Concludes, Check Your Result Now!

Siddhartha Equity Fund has concluded its public issue allotment today at Siddhartha Capital Limited, Naxal, Kathmandu.

Applicants who had applied up to 8 lakh units (up to Rs 80 lakh) were allotted as much as they had applied for. Among 41 applicants who had applied 10 lakh units to 24 lakh units (Rs 1 crore to Rs 2.40 crore), 33 applicants were allotted 967,748 units each and 8 applicants were allotted 967,747 units each. The remaining 2.25 crore units were allotted to Siddhartha Bank as the fund sponsor.

Out of 29,573 applicants, 29,549 applicants were allotted. There were 24 invalid applicants.

Although Siddhartha Equity Fund had floated its public issue of 12 crore unit shares worth Rs 1.20 arba, the fund size was increased by 25% to Rs 1.50 arba due to oversubscription. SEF had floated public issue from Ashwin 25, 2074 to Ashwin 30, 2074. 15% units was reserved for Siddhartha Bank.

Siddhartha Equity Fund is a closed-end 10-years equity oriented mutual fund scheme with fund size of Rs 1.50 arba. The mutual fund is managed by Siddhartha Capital Limited and Siddhartha Bank Limited is its fund sponsor.

Siddhartha Capital already has its two mutual fund schemes named Siddhartha Investment Growth Scheme (SIGS1) and Siddhartha Equity Oriented Scheme (SEOS), and both are listed in NEPSE.

Siddhartha Equity Oriented Limited (SEOS) and Siddhartha Investment Growth Scheme-1 (SIGS1)—closed-end 5 years mutual fund schemes, SIGS1 and SEOS have reported net asset value (NAV) of Rs 21.55 and Rs 13.21 respectively in Ashwin 2074 end.

Check the link below to see the result at Sharesansar Site:

RESULT LINK

Check the link below to see the result at Bizpati Site:

RESULT LINK

Check the link below to see the result at Siddhartha Capital Site:

RESULT LINK

Check the link below to see all allottees list in excel format:

RESULT FULL ALLOTTEES LIST (excel)

ShareUpdateNepal: Sunday 12th November 2017

Friday, November 10, 2017

Urinalysis Quality Control at the Point-of-Care !

Clinical Issues

The goal of any clinical diagnostic test procedure is to provide critical information in a timely manner so that appropriate actions may be taken, ultimately improving patient outcomes. Point-of-care testing (POCT) is a term that has come to describe a multitude of rapid medical tests that can be performed at or near the site of patient care. The most compelling benefit of these tests is that, as opposed to having to wait hours or days for results to arrive from an outside laboratory, clinicians can obtain the results immediately, allowing for clinical management decisions to be made while the patient is still at the care facility. While the implementation of rapid diagnostic tests dates back to ancient history (sweet-tasting urine was once commonly used to diagnose diabetes mellitus), it was not until the 1950s that these rapid diagnostic methods gained any real predictive value. Today, the popularity and demand for POCT are increasing rapidly. TriMark Publications estimates that the global market for POCT was $14.5 billion in 2016, and is expected to grow by seven percent over the next five years.

Urinalysis dipsticks at the point-of-care:

Urinalysis using multi-analyte dipsticks is a point-of-care test performed at any hospital, clinical laboratory, doctor’s office, health clinic, and nursing facility. Various iterations of these tests have existed for decades, and they continue to be among the most commonly performed tests of any kind. Urinalysis dipsticks contain discrete reagent pads to semi-quantitatively test for the presence of bilirubin, blood, creatinine, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen in a urine sample.

Source: MedicalLaboratoryObserver

Practical Textbook of Biochemistry for Medical Students 2nd Edition !

Practical Textbook of Biochemistry for Medical Students 2nd Edition pdf

Practical Textbook of Biochemistry for Medical Students 2nd Edition ebook

This book is in resonance with the Textbook of Biochemistry for Medical Students, by Vasudevan et al, which is now in the 7th edition. That textbook is now accepted not only inside India, but also various other countries in the world. The Spanish edition of the Textbook is already in market and a Russian edition is in preparation. Students are advised to clear the doubts by going through that main textbook. This practical book is prepared after consulting the syllabi of MBBS course of various universities. The contents are divided into qualitative and quantitative experiments, which the students are supposed to do by themselves in the practical classes. Further, a few more experiments are given, which may not be possible for the student to do by himself/herself. Some of these will be demonstrated in the practical classes. In the end, a few case reports are also included, which will be useful for the students to prepare the practical examinations.

Printed Pages: 162.

Bookseller Inventory # 95567

Editorial Reviews

Brand New Book in Perfect Condition.Fast Shipping with tracking number.

Product details

Paperback: 162 pages
Publisher: Jp Medical Ltd; 2nd Revised ed. edition (July 1, 2013)
Language: English
ISBN-10: 9350906686
ISBN-13: 978-9350906682

Practical Textbook of Biochemistry for Medical Students 2nd Edition free download

Download

Thursday, November 9, 2017

Gut Bacteria And The Brain: Are We Controlled By Microbes?

Although the interaction between our brain and gut has been studied for years, its complexities run deeper than initially thought. It seems that our minds are, in some part, controlled by the bacteria in our bowels.

The gut has defenses against pathogens, but, at the same time, it encourages the survival and growth of "healthy" gut bacteria.

The vast majority of these single-celled visitors are based in the colon, where no less than 1 trillion reside in each gram of intestinal content.

Estimating the number of bacterial guests in our gut is challenging; to date, the best guess is that 40 trillion bacteria call our intestines home - partially dependent on the size of your last bowel movement (poop's major ingredient is bacteria).

How much sway can a microbe hold? Bacterial influence over human psychology is slowly coming
into focus.

Source: medicalnewstoday

Tuesday, November 7, 2017

Support Microfinance IPO Allotment by Lottery, 10 Kitta Shares to Elligible Applicants !

Support Microfinance Bittiya Sanstha Ltd. (SMFBL) has allocated its Initial Public Offering (IPO) today, Wednesday. According to NMB Capital Ltd., the issue manager of the microfinance, out of 226,932 applicants, only 16,740 applicants are allotted 10 units of mandatory shares through the lottery system.

Of the total 226,932 IPO share applications worthing Rs. 2.24 billion, 210,192 were canceled. The microfinance headquartered at Itahari issued 180,000 units of IPO shares to general public worth Rs. 18 million from 4th to 9th October 2017. The issuance was oversubscribed by 27.69 times.

Out of the total shares, the company allocated 3,600 units (2%) and 9000 units (5%) of shares for employees and mutual funds respectively.

As per the statistics provided by NMB Capital, only 7.38% of the total applicants are provided the shares.

Currently, the company has a paid-up capital of Rs. 42 million. After this IPO issuance, it will reach Rs. 60 million. The microfinance earned a net profit of Rs. 4.8 million in the last Fiscal Year (FY). The company has Rs. 3.119 million in its reserve fund.